The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,585,737 in first-year total cost, median $595,931.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-Q (J2)]8
Most frequent institutions
- DUKE UNIVERSITY2
- CORNELL UNIVERSITY1
- EMORY UNIVERSITY1
- UNIVERSITY COLLEGE LONDON1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Breast core-needle diagnostics in LMICs via millifluidics and direct-to-digital imaging: development and validation in Ghana1U01CA269191-01 | LEVENSON, RICHARD M.SEIBEL, ERIC JWIAFE, SETHWIAFE-ADDAI, BEATRICE | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $641,883 | ZCA1 |
| 2022 | Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE1U01CA269199-01 | CESARMAN, ETHELERICKSON, DAVID CARLMARTIN, JEFFREY NSEMEERE, AGGREY SEMWENDERO | CORNELL UNIVERSITY, NY | $657,369 | ZCA1 |
| 2022 | Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening1U01CA269192-01 | BUKUSI, ELIZABETH ANNEHUCHKO, MEGAN J.RAMANUJAM, NIRMALA | DUKE UNIVERSITY, NC | $604,108 | ZCA1 |
| 2022 | An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit1U01CA269181-01 | MADABHUSHI, ANANTPARMAR, VANI | EMORY UNIVERSITY, GA | $603,042 | ZCA1 |
| 2022 | KeyScope: The Key to Sustainable Cancer Diagnosis and Treatment in Uganda1U01CA269190-01 | FITZGERALD, TAMARA N | DUKE UNIVERSITY, NC | $588,819 | ZCA1 |
| 2022 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care1U01CA269147-01 | LIU, CHANGCHUN | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | $547,265 | ZCA1 |
| 2022 | Adapting a point of use test card, the chemoPAD, for protecting chemotherapy drug quality in sub-Saharan Africa1U01CA269195-01 | LIEBERMAN, MARYA | UNIVERSITY OF NOTRE DAME, IN | $485,863 | ZCA1 |
| 2022 | ARCHERY: Artificial Intelligence based Radiotherapy treatment planning for Cervical and Head and Neck cancer1U01CA269143-01 | AGGARWAL, AJAY | UNIVERSITY COLLEGE LONDON | $457,388 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.